Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ICP-538 in Healthy Subjects

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This is a Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ICP-538 in Healthy Subjects
Epistemonikos ID: c73cc9787508172551384ff25d7ecf7c2da9d878
First added on: Apr 17, 2026